September Month in Review: Top Stories on Drug Topics®


Take a look back at our most popular news from September 2022.

Did you miss the top stories on Drug Topics® this month? Catch up on these noteworthy stories today.

10. Women and CBD: Increased Interest, but Caution Is Warranted

CBD can be used to treat a myriad of women’s health conditions, but research is still limited.

9. The Evolution of the CBD Regulatory Landscape

No federal agency has taken charge of regulating cannabidiol products, leaving decisions up to the individual states.

8. Tips for Managing Diabetes Comorbidities

Considering comorbidities is just as important as lowering patient HbA1c.

7. How Pharmacists Can Address Vaccine Hesitancy for the Flu and Beyond

Address vaccine hesitancy at your pharmacy to encourage patients and their families to get vaccinated against COVID-19, flu, and more.

6. FDA Approves Voquezna for Helicobacter pylori Infection in Adults

This new treatment option copackages 3 drugs for optimal treatment.

5. Mitigating Costs of Cancer Treatment: The Role of Pharmacists

Cancer care is expensive, but pharmacists can help.

4. FDA, Medtronic Alert Users to Cybersecurity Risk with MiniMed 600 Systems

The risk could allow unauthorized users to change insulin levels.

3. Impact of Laws on Pediatric Opioid Prescriptions

Are prescription cap laws for opioids effective for children and teenagers?

2. Maternal Vaccination Cut the Risk of COVID-19 Hospitalization for Infants

Infants of fully vaccinated mothers had fewer cases of hospitalization from COVID-19 than those unvaccinated.

1. Waste Problem Shows COVID-19 Vaccines Aren’t Just a Dime a Dozen

When it comes to the COVID-19 vaccine, independent pharmacies are being set up to fail by federal health partners.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.